Clinical Trial Update: Haemate HS in Patients With Severe Bleeding Undergoing Valve Replacement Due to Aortic Stenosis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Haemate HS for managing severe surgical bleeding in patients undergoing aortic valve replacement due to aortic stenosis has been with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Stenosis

Drugs mentioned

• Haemate HS (von Willebrand factor/vIII concentrate)

Snippet

Sponsor: Heinrich-Heine University, Duesseldorf | Conditions: Blood Loss, Surgical | Phase 2 | Status: WITHDRAWN